首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
到
2008 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
检索 清除
手术分类
  • 全部（2447）
  • 腹部手术（342）
  • 胸科手术（70）
  • 血管手术（5）
  • 心脏手术（97）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（77）
  • 日间手术（26）
  • 手术室外（28）
  • 创伤和烧伤（0）
  • 非心脏手术（472）
  • 老年（0）
  • 小儿新生儿（189）
  • 特殊患者（42）
  • 未说明手术类型（982）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（62）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 463 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/463.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => In the presence of heparin resistance and in absence of antithrombin deficiency, we suggest the administration of an additional 100 units/kg. (2C) [laiyuan] => 如果出现肝素抗性和抗凝血酶缺乏症，建议追加100u/kg的剂量。（证据等级：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
如果出现肝素抗性和抗凝血酶缺乏症，建议追加100u/kg的剂量。（证据等级：低；推荐强度：弱推荐）

In the presence of heparin resistance and in absence of antithrombin deficiency, we suggest the administration of an additional 100 units/kg. (2C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 464 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/464.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend an initial dose of 400 units/kg of unfractionated heparin prior to CPB initiation. (1C) [laiyuan] => 推荐在开始体外循环之前使用初始剂量为400u/kg的肝素。（证据等级：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
推荐在开始体外循环之前使用初始剂量为400u/kg的肝素。（证据等级：低；推荐强度：强推荐）

We recommend an initial dose of 400 units/kg of unfractionated heparin prior to CPB initiation. (1C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 465 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/465.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend targeting an ACT > 480 sec before and throughout CPB. (1B) [laiyuan] => 推荐在体外循环（CPB）之前和整个体外循环过程中，ACT>480s。（证据等级：中；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
推荐在体外循环（CPB）之前和整个体外循环过程中，ACT>480s。（证据等级：中；推荐强度：强推荐）

We recommend targeting an ACT > 480 sec before and throughout CPB. (1B)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 466 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/466.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend the use of whole blood activated clotting time or heparin concentration to assess heparin response in neonates and children. (1B) [laiyuan] => 推荐使用全血活化凝血时间或肝素浓度来评估新生儿和儿童对肝素的反应。（证据等级：中；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
推荐使用全血活化凝血时间或肝素浓度来评估新生儿和儿童对肝素的反应。（证据等级：中；推荐强度：强推荐）

We recommend the use of whole blood activated clotting time or heparin concentration to assess heparin response in neonates and children. (1B)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 467 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/467.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend against the use of routine ANH in patients undergoing cardiac surgery with CPB. (1C) [laiyuan] => 建议对接受体外循环心脏手术的患者不使用常规血液稀释（ANH）。（证据等级：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
建议对接受体外循环心脏手术的患者不使用常规血液稀释（ANH）。（证据等级：低；推荐强度：强推荐）

We recommend against the use of routine ANH in patients undergoing cardiac surgery with CPB. (1C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 468 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/468.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We suggest active salvaging of CPB circuit residual blood as it may decrease the number of transfusions. (2C) [laiyuan] => 建议积极回收体外循环环路残余血，因为这样可以减少输血次数。（证据等级：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
建议积极回收体外循环环路残余血，因为这样可以减少输血次数。（证据等级：低；推荐强度：弱推荐）

We suggest active salvaging of CPB circuit residual blood as it may decrease the number of transfusions. (2C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 469 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/469.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend the use of cell salvage in pediatric cardiac surgery in order to reduce perioperative transfusion. (1C) [laiyuan] => 为了减少围手术期输血，推荐在小儿心脏手术中使用血液回收。（证据等级：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
为了减少围手术期输血，推荐在小儿心脏手术中使用血液回收。（证据等级：低；推荐强度：强推荐）

We recommend the use of cell salvage in pediatric cardiac surgery in order to reduce perioperative transfusion. (1C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 470 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/470.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend conventional ultrafiltration or ≥ 10 min of modified ultrafiltration for neonates and infants undergoing cardiac surgery with CPB. (1B) [laiyuan] => 建议对接受体外循环心脏手术的新生儿和婴儿进行常规超滤或≥10min的改良超滤 （证据等级：中；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
建议对接受体外循环心脏手术的新生儿和婴儿进行常规超滤或≥10min的改良超滤 （证据等级：中；推荐强度：强推荐）

We recommend conventional ultrafiltration or ≥ 10 min of modified ultrafiltration for neonates and infants undergoing cardiac surgery with CPB. (1B)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 471 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/471.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend colloids (e.g. albumin) should be preferred over crystalloids for clear priming in children undergoing cardiac surgery. (1C) [laiyuan] => 推荐对于接受心脏手术的儿童，预冲液胶体（如白蛋白）应优于晶体液。（证据等级：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
推荐对于接受心脏手术的儿童，预冲液胶体（如白蛋白）应优于晶体液。（证据等级：低；推荐强度：强推荐）

We recommend colloids (e.g. albumin) should be preferred over crystalloids for clear priming in children undergoing cardiac surgery. (1C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 472 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/472.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We suggest the addition of red blood cells to maintain a hematocrit > 24% during CPB based on the estimation of the degree of hemodilution related to CPB prime and cardioplegia. (2C) [laiyuan] => 根据体外循环预冲液和停跳液对血液稀释程度的评估，我们建议在体外循环期间补充红细胞，以保持血细胞比容大于24%。（证据等级：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
根据体外循环预冲液和停跳液对血液稀释程度的评估，我们建议在体外循环期间补充红细胞，以保持血细胞比容大于24%。（证据等级：低；推荐强度：弱推荐）

We suggest the addition of red blood cells to maintain a hematocrit > 24% during CPB based on the estimation of the degree of hemodilution related to CPB prime and cardioplegia. (2C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技